English
Regional settings| Spread | 13.6 | ||||
 Long position overnight feeLong position overnight fee
Trade size with leverage ~ ¥5,000 Short position overnight fee ~ ¥4,000 | -0.011244% | ||||
| Short position overnight fee Short position overnight fee
Trade size with leverage ~ ¥5,000 Short position overnight fee ~ ¥4,000 | -0.010978% | ||||
| Overnight fee time | 21:00 (UTC) | ||||
| Currency | JPY | ||||
| Min traded quantity | 1 | ||||
| Margin | 20 | ||||
| Stock exchange | Japan | ||||
| Commission on trade1 | 0% |
1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information
| Prev. Close | 2167 |
| Open | 2195.1 |
| 1-Year Change | -7.13% |
| Day's Range | 2181.3 - 2214.6 |
Olympus Corp is a Japan-based company mainly engaged in the manufacture and sale of endoscopes, therapeutic equipment, science, video and other products. The Company operates in five business segments. The Endoscopy segment provides gastrointestinal endoscopy, surgical endoscopy, endoscopy systems and repair services. The Therapeutic Equipment segment provides endoscopic treatment tools, energy devices, urology, gynecology and otolaryngology products. The Scientific segment provides biological microscope, industrial microscope, industrial endoscope and non-destructive inspection equipment. The Imaging segment provides digital cameras and recording machines. The Others segment is engaged in the manufacture and sale of biomaterials. The Company is also engaged in the financial investment business.
BRIEF: For the nine months ended 31 December 2021, Olympus Corp revenues increased 23% to Y629.76B. Net income before extraordinary items increased 63% to Y87.67B. Revenues reflect Therapeutic Devices segment increase of 39% to Y203.71B, Endoscope segment increase of 13% to Y304.24B, Science segment increase of 24% to Y82.85B, Americas (Region) segment increase of 28% to Y212.24B, Europe segment increase of 24% to Y157.95B.
10/2003, Name changed from Olympus Optical Corp. FY'94-'02 all WAS were estimated. FY'04-'07 1Q&3Q WAS was estimated and used as O/S. FY'08 Q1&Q3 WAS=O/S. FY'2010 Q1 DWAS was estimated.
